v3.26.1
Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Amortized cost $ 935,765 [1],[2],[3],[4] $ 936,824 [5],[6],[7],[8]
Common Stock, par value $ 0.001 $ 0.001
Common Stock, unlimited authorized Unlimited Unlimited
Common Stock, shares issued 19,029,710 18,631,405
Common Stock, shares outstanding 19,029,710 18,631,405
Secured Loan Facility [Member]    
Deferred financing costs $ 2,354 $ 2,740
Credit Facility [Member]    
Deferred financing costs 572 630
Debt issuance costs, Line of credit arrangements, Net 572 630
Non-controlled and Non-affiliated investments [Member]    
Amortized cost 919,473 920,814
Non-controlled Affiliated Investment [Member]    
Amortized cost 2,737 2,510
Controlled Affiliated Investment [Member]    
Amortized cost $ 13,555 $ 13,500
[1] All investments domiciled in the United States unless otherwise noted.
[2] Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be “restricted security” under the Securities Act. As of June 30, 2026, the aggregate fair value of these securities is $22,541, or 4.72% of the Fund’s net assets.
[3] The Fund updated certain descriptions of its portfolio companies presented in the consolidated financial statements as of June 30, 2026 to align with the legal issuer name, where applicable. These updates had no impact on the Consolidated Statements of Assets and Liabilities as of June 30, 2026.
[4] Unless otherwise noted, the fair value of investments with respect to securities for which market quotations are not readily available are valued using significant unobservable inputs (See Note 3—Fair Value of Financial Instruments).
[5] All investments domiciled in the United States unless otherwise noted.
[6] The Fund updated certain descriptions of its portfolio companies presented in the consolidated financial statements as of December 31, 2025 to align with the legal issuer name, where applicable. These updates had no impact on the Consolidated Statements of Assets and Liabilities as of December 31, 2025.
[7] This security is restricted and not available for resale.
[8] Unless otherwise noted, the fair value of investments with respect to securities for which market quotations are not readily available are valued using significant unobservable inputs (See Note 3—Fair Value of Financial Instruments).